Pages that link to "Q28280099"
Jump to navigation
Jump to search
The following pages link to Use of multiple biomarkers to improve the prediction of death from cardiovascular causes (Q28280099):
Displaying 50 items.
- Olfactory dysfunction predicts 5-year mortality in older adults (Q21131947) (← links)
- Nocturia, sleep-disordered breathing, and cardiovascular morbidity in a community-based cohort (Q21134791) (← links)
- Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia (Q21194921) (← links)
- Systems medicine: the future of medical genomics and healthcare (Q24288895) (← links)
- Classical and novel biomarkers for cardiovascular risk prediction in the United States (Q26824026) (← links)
- Identifying novel biomarkers for cardiovascular disease risk prediction (Q26865722) (← links)
- Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needs (Q28067081) (← links)
- Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure (Q28243166) (← links)
- CRP in cardiovascular disease (Q28268282) (← links)
- Identification of early biomarkers during acetaminophen-induced hepatotoxicity by fourier transform infrared microspectroscopy (Q28483876) (← links)
- Framingham risk score with cardiovascular events in chronic kidney disease (Q28488483) (← links)
- GDF-15 for prognostication of cardiovascular and cancer morbidity and mortality in men (Q28535575) (← links)
- Coronary risk assessment among intermediate risk patients using a clinical and biomarker based algorithm developed and validated in two population cohorts (Q28686330) (← links)
- Incremental effects of endocrine and metabolic biomarkers and abdominal obesity on cardiovascular mortality prediction (Q28731264) (← links)
- A genome-wide association study identifies rs2000999 as a strong genetic determinant of circulating haptoglobin levels (Q28731542) (← links)
- Self-perceived quality of life predicts mortality risk better than a multi-biomarker panel, but the combination of both does best (Q28741640) (← links)
- Epidemiology of cardiovascular disease: recent novel outlooks on risk factors and clinical approaches (Q30251632) (← links)
- Recurring exon deletions in the HP (haptoglobin) gene contribute to lower blood cholesterol levels. (Q30384714) (← links)
- Inflammatory markers and outcomes in cardiovascular disease (Q30878922) (← links)
- Immunoexpression analysis and prognostic value of BLCAP in breast cancer (Q31103058) (← links)
- Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis (Q31126960) (← links)
- Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events? (Q33474334) (← links)
- Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic proteomic markers of arteriosclerosis study (Q33530066) (← links)
- Assessing the cost effectiveness of using prognostic biomarkers with decision models: case study in prioritising patients waiting for coronary artery surgery (Q33598869) (← links)
- Seeking a unique lipid signature predicting cardiovascular disease risk (Q33600581) (← links)
- Circulating progenitor cell count for cardiovascular risk stratification: a pooled analysis (Q33633882) (← links)
- Indicators of "healthy aging" in older women (65-69 years of age). A data-mining approach based on prediction of long-term survival (Q33661044) (← links)
- Oxidative stress: Biomarkers and novel therapeutic pathways (Q33682262) (← links)
- New strategies for Alzheimer's disease and cognitive impairment (Q33717008) (← links)
- Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing. (Q33733517) (← links)
- Markers of atherosclerosis and inflammation for prediction of coronary heart disease in older adults (Q33741530) (← links)
- NT-proBNP and circulating inflammation markers in prediction of a normal myocardial scintigraphy in patients with symptoms of coronary artery disease (Q33769784) (← links)
- Context-dependent associations between variation in risk of ischemic heart disease and variation in the 5' promoter region of the apolipoprotein E gene in Danish women (Q33775392) (← links)
- Plasma protein profiling reveals protein clusters related to BMI and insulin levels in middle-aged overweight subjects (Q33784462) (← links)
- Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury (Q33808300) (← links)
- The "O" class: crafting clinical care with FoxO transcription factors (Q33824809) (← links)
- Biomarkers in peripheral arterial disease patients and near- and longer-term mortality (Q33828811) (← links)
- Plasma NT-proBNP as predictor of change in functional status, cardiovascular morbidity and mortality in the oldest old: the Leiden 85-plus study (Q33848664) (← links)
- Prevalence of low ankle-brachial index, elevated plasma fibrinogen and CRP across Framingham risk categories: Data from the National Health and Nutrition Examination Survey (NHANES) 1999–2004 (Q33849562) (← links)
- Improved risk stratification in prevention by use of a panel of selected circulating microRNAs (Q33866958) (← links)
- Long-term trajectory of two unique cardiac biomarkers and subsequent left ventricular structural pathology and risk of incident heart failure in community-dwelling older adults at low baseline risk (Q33873812) (← links)
- Reclassification of risk of death with the knowledge of D-dimer in a cohort of treated HIV-infected individuals (Q33917180) (← links)
- Biomarkers and cardiovascular risk assessment for primary prevention: an update (Q33927398) (← links)
- Association of cystatin C with adverse outcomes. (Q33932292) (← links)
- Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg case-cohort study (Q33932928) (← links)
- Natriuretic Peptides and Assessment of Cardiovascular Disease Risk in Asymptomatic Persons (Q33948944) (← links)
- Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey (Q33972551) (← links)
- Applying measures of discriminatory accuracy to revisit traditional risk factors for being small for gestational age in Sweden: a national cross-sectional study (Q33996015) (← links)
- Association of NT-proBNP and multiple biomarkers with severity of angiographic coronary artery disease in diabetic and pre-diabetic Chinese patients. (Q33998920) (← links)
- Multiple markers of inflammation and weight status: cross-sectional analyses throughout childhood (Q34017966) (← links)